Search Results

Frontrunners in CNS Drug Delivery: Novel delivery technologies enhance brain penetration to target neurodegenerative diseases and glioblastomas.

• Authors : Barton, Cheryl¹

Subjects: *DIFFUSION of innovations; DRUG therapy for Parkinson's disease; GENE therapyUNITED States. Food & Drug Administration

• Source: Pharmaceutical Technology Europe. May2024, Vol. 36 Issue 5, p15-19. 4p.

Record details

FDA Approval Granted for Novel Parkinson's Treatment.

• Authors : Lutton, Logan

Subjects: DRUG therapy for Parkinson's disease; COMBINATION drug therapy; CONTROLLED release preparationsUNITED States. Food & Drug Administration

• Source: Formulary Watch. 8/9/2024, p1-1. 1p.

Record details

Validity and reliability of linear encoder muscle power testing in persons with Parkinson's disease.

• Authors : Bonde-Jensen, Frederik; Dalgas, Ulrik; Hvid, Lars Grøndahl

Subjects: DRUG therapy for Parkinson's disease; MULTITRAIT multimethod techniques; SECONDARY analysisDENMARK

• Source: Clinical Rehabilitation. May2024, Vol. 38 Issue 5, p678-687. 10p.

Record details

A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living.

• Authors : Sun, Weibo (AUTHOR); Wang, Qingyong (AUTHOR); Yang, Tiansong (AUTHOR)

Subjects: DRUG therapy for Parkinson's disease; SULFUR compounds; DOPAMINE agonists

• Source: Neurological Sciences. Oct2022, Vol. 43 Issue 10, p5821-5837. 17p. 1 Diagram, 4 Charts, 3 Graphs.

Record details

FDA Issues Second CRL for Parkinson's Therapy.

Subjects: *PHARMACEUTICAL industry; DRUG therapy for Parkinson's disease; INFUSION therapy equipmentUNITED States. Food & Drug Administration

• Source: Formulary Watch. 4/9/2024, p1-1. 1p.

Record details

Recent Advances in Drug Therapy for Parkinson's Disease.

• Authors : Murakami H; Department of Neurology, the Jikei University School of Medicine, Japan.; Shiraishi T

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Neurodegenerative Diseases*/Neurodegenerative Diseases*/Neurodegenerative Diseases*/drug therapy; Humans

• Source: Internal medicine (Tokyo, Japan) [Intern Med] 2023 Jan 01; Vol. 62 (1), pp. 33-42. Date of Electronic Publication: 2022 Feb 01.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease.

• Authors : Rizzone, Mario Giorgio (AUTHOR); Mancini, Francesca (AUTHOR); Artusi, Carlo Alberto (AUTHOR)

Subjects: DRUG therapy for Parkinson's disease; DEEP brain stimulation; DIENCEPHALON

• Source: Neurological Sciences. May2022, Vol. 43 Issue 5, p3187-3193. 7p. 3 Charts.

Record details

Amneal Resubmits Application for Novel Parkinson's Therapy.

Subjects: DRUG therapy for Parkinson's disease; DRUG approval; DOPAUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/9/2024, p1-1. 1p.

Record details

Treating Parkinson's Psychosis.

• Authors : Coggins, Mark D.

Subjects: DRUG therapy for psychoses; DRUG therapy for Parkinson's disease; DOPAMINE agonists

• Source: Today's Geriatric Medicine. Nov/Dec2023, Vol. 16 Issue 6, p22-25. 4p.

Record details

Zonisamide in Parkinson's disease: a current update.

• Authors : Goel, Atul (AUTHOR); Sugumaran, Ramkumar (AUTHOR); Narayan, Sunil K. (AUTHOR)

Subjects: DRUG therapy for Parkinson's disease; DOPA; DOPAMINE

• Source: Neurological Sciences. Oct2021, Vol. 42 Issue 10, p4123-4129. 7p. 2 Diagrams, 3 Charts.

Record details